Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway

INTRODUCTION: Cell-based therapy represents a new frontier in the treatment of a wide variety of human diseases traditionally associated with morbidity outcomes, including those involving inflammation, autoimmunity, tissue damage, and cancer. However, the use of mesenchymal stem cells (MSCs) to trea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Atsuta, Ikiru, Liu, Shiyu, Miura, Yasuo, Akiyama, Kentaro, Chen, Chider, An, Ying, Shi, Songtao, Chen, Fa-Ming
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2013
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854680/
https://ncbi.nlm.nih.gov/pubmed/24025590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/scrt322
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares